Patents by Inventor Diego Cadavid

Diego Cadavid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating Disorders
    Publication number: 20210403556
    Abstract: Dosage regimens, methods, compositions and kits are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Application
    Filed: February 12, 2021
    Publication date: December 30, 2021
    Inventors: Diego Cadavid, Lei Xu, Lin Xu
  • LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20210277111
    Abstract: Methods, compositions and kits are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Application
    Filed: December 18, 2020
    Publication date: September 9, 2021
    Inventors: Diego Cadavid, Sha Mi
  • Combination Therapies and Uses for Treatment of Demyelinating Disorders
    Publication number: 20210260185
    Abstract: Methods and compositions for enhancing one or more of: myelination, re-myelination, oligodendrocyte numbers, or neuroaxonal protection, while ameliorating an inflammatory condition in a human subject are disclosed. In certain embodiments, the methods and compositions described herein include a reparative agent (e.g., a LINGO-1 antagonist) and an immunomodulatory agent, in combination. Thus, methods, compositions and kits described herein can be useful for treating a CNS demyelinating disease.
    Type: Application
    Filed: November 30, 2020
    Publication date: August 26, 2021
    Applicant: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • Combination Therapies and Uses for Treatment of Demyelinating Disorders
    Publication number: 20200276303
    Abstract: Methods and compositions for enhancing one or more of: myelination, re-myelination, oligodendrocyte numbers, or neuroaxonal protection, while ameliorating an inflammatory condition in a human subject are disclosed. In certain embodiments, the methods and compositions described herein include a reparative agent (e.g., a LINGO-1 antagonist) and an immunomodulatory agent, in combination. Thus, methods, compositions and kits described herein can be useful for treating a CNS demyelinating disease.
    Type: Application
    Filed: December 10, 2019
    Publication date: September 3, 2020
    Applicant: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20200216533
    Abstract: Methods, compositions and kits are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Application
    Filed: October 1, 2019
    Publication date: July 9, 2020
    Applicant: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating Disorders
    Publication number: 20200031924
    Abstract: Dosage regimens, methods, compositions and kits are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Application
    Filed: July 12, 2017
    Publication date: January 30, 2020
    Inventors: Diego Cadavid, Lei Xu, Lin Xu
  • LINGO-1 antagonists and uses for treatment of demyelinating disorders
    Patent number: 10435467
    Abstract: Methods, compositions and kits comprising an anti-LINGO antibody molecule are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: October 8, 2019
    Assignee: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • Combination Therapies and Uses for Treatment of Demyelinating Disorders
    Publication number: 20190038744
    Abstract: Methods and compositions for enhancing one or more of: myelination, re-myelination, oligodendrocyte numbers, or neuroaxonal protection, while ameliorating an inflammatory condition in a human subject are disclosed. In certain embodiments, the methods and compositions described herein include a reparative agent (e.g., a LINGO-1 antagonist) and an immunomodulatory agent, in combination. Thus, methods, compositions and kits described herein can be useful for treating a CNS demyelinating disease.
    Type: Application
    Filed: February 20, 2018
    Publication date: February 7, 2019
    Applicant: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • LINGO-1 ANTAGONISTS AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20180148505
    Abstract: Methods, compositions and kits comprising an anti-LINGO antibody molecule are described herein useful for detecting and/or treating a CNS demyelinating disease.
    Type: Application
    Filed: January 8, 2016
    Publication date: May 31, 2018
    Applicant: Biogen MA Inc.
    Inventors: Diego Cadavid, Sha Mi
  • Cognitive composite parameters and uses thereof for evaluating multiple sclerosis
    Patent number: 9717453
    Abstract: Methods, systems and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis are disclosed.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: August 1, 2017
    Assignee: BIOGEN IDEC MA INC.
    Inventors: Diego Cadavid, David Erlanger, John DeLuca, Ralph Benedict, Frederick W. Foley, Jeffrey A. Wilken
  • BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF
    Publication number: 20160045570
    Abstract: Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are disclosed.
    Type: Application
    Filed: July 14, 2015
    Publication date: February 18, 2016
    Inventors: Steven Bushnell, Alexander Michael Buko, Eric Taylor Whalley, Christopher Stebbins, Zhenming Zhao, Diego Cadavid
  • COMBINATION THERAPIES AND USES FOR TREATMENT OF DEMYELINATING DISORDERS
    Publication number: 20150238602
    Abstract: Methods and compositions for enhancing one or more of: myelination, re-myelination, oligodendrocyte numbers, or neuroaxonal protection, while ameliorating an inflammatory condition in a human subject are disclosed. In certain embodiments, the methods and compositions described herein include a reparative agent (e.g., a LINGO-1 antagonist) and an immunomodulatory agent, in combination. Thus, methods, compositions and kits described herein can be useful for treating a CNS demyelinating disease.
    Type: Application
    Filed: October 8, 2013
    Publication date: August 27, 2015
    Inventors: Diego Cadavid, Sha Mi
  • DISEASE PROGRESSION PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS
    Publication number: 20150220693
    Abstract: Methods, systems and kits to detect and/or quantify disease progression in a subject having a progressive form of MS are disclosed.
    Type: Application
    Filed: August 8, 2013
    Publication date: August 6, 2015
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Diego Cadavid, Deborah Ann Kinch, Sophia Lee, Lei Xu
  • COGNITIVE COMPOSITE PARAMETERS AND USES THEREOF FOR EVALUATING MULTIPLE SCLEROSIS
    Publication number: 20150110741
    Abstract: Methods, systems and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis are disclosed.
    Type: Application
    Filed: April 19, 2013
    Publication date: April 23, 2015
    Inventors: Diego Cadavid, David Erlanger, John DeLuca, Ralph Benedict, Frederick W. Foley, Jeffrey A. Wilken
  • BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF
    Publication number: 20120328567
    Abstract: Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are disclosed.
    Type: Application
    Filed: April 6, 2012
    Publication date: December 27, 2012
    Inventors: Steven Bushnell, Alexander Michael Buko, Eric Taylor Whalley, Christopher Stebbins, Zhenming Zhao, Diego Cadavid